Annual Drug Patent Expirations for VYLEESI+%28AUTOINJECTOR%29
Vyleesi (autoinjector) is a drug marketed by Palatin Technologies and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
This drug has seventy-three patent family members in twenty-four countries.
The generic ingredient in VYLEESI (AUTOINJECTOR) is bremelanotide acetate. One supplier is listed for this compound. Additional details are available on the bremelanotide acetate profile page.
For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com
